190 related articles for article (PubMed ID: 37435002)
21. Prognostic Significance of Fms-Like Tyrosine Kinase 3 Internal Tandem Duplication Mutation in Non-Transplant Adult Patients with Acute Myeloblastic Leukemia: A Systematic Review and Meta-Analysis.
Rinaldi I; Louisa M; Wiguna FI; Budiani E; Mahardhika JC; Hukmi K
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2827-2836. PubMed ID: 33112537
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis.
Liu WJ; Tan XH; Luo XP; Guo BP; Wei ZJ; Ke Q; He S; Cen H
Leuk Lymphoma; 2014 Dec; 55(12):2691-8. PubMed ID: 24524305
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value of CD11b Expression Level for Acute Myeloid Leukemia Patients: A Meta-Analysis.
Xu S; Li X; Zhang J; Chen J
PLoS One; 2015; 10(8):e0135981. PubMed ID: 26309131
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of U2AF1 mutant in patients with de novo myelodysplastic syndromes: a meta-analysis.
Wang H; Zhang N; Wu X; Zheng X; Ling Y; Gong Y
Ann Hematol; 2019 Dec; 98(12):2629-2639. PubMed ID: 31754743
[TBL] [Abstract][Full Text] [Related]
25.
Shin DY
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835510
[TBL] [Abstract][Full Text] [Related]
26. Establishment of tumor protein p53 mutation-based prognostic signatures for acute myeloid leukemia.
Xie J; Chen K; Han H; Dong Q; Wang W
Curr Res Transl Med; 2022 Sep; 70(4):103347. PubMed ID: 35483237
[TBL] [Abstract][Full Text] [Related]
27. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
28. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
29. FLT3-TKD in the prognosis of patients with acute myeloid leukemia: A meta-analysis.
Li S; Li N; Chen Y; Zheng Z; Guo Y
Front Oncol; 2023; 13():1086846. PubMed ID: 36874106
[TBL] [Abstract][Full Text] [Related]
30. Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
Becker H; Pfeifer D; Ihorst G; Pantic M; Wehrle J; Rüter BH; Bullinger L; Hackanson B; Germing U; Kuendgen A; Platzbecker U; Döhner K; Ganser A; Hagemeijer A; Wijermans PW; Döhner H; Duyster J; Lübbert M
Ann Hematol; 2020 Jul; 99(7):1551-1560. PubMed ID: 32504186
[TBL] [Abstract][Full Text] [Related]
31. Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine-based chemotherapy.
Ni J; Hong J; Long Z; Li Q; Xia R; Zeng Q
Int J Lab Hematol; 2020 Dec; 42(6):849-857. PubMed ID: 32730663
[TBL] [Abstract][Full Text] [Related]
32. Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.
Ribeiro AF; Pratcorona M; Erpelinck-Verschueren C; Rockova V; Sanders M; Abbas S; Figueroa ME; Zeilemaker A; Melnick A; Löwenberg B; Valk PJ; Delwel R
Blood; 2012 Jun; 119(24):5824-31. PubMed ID: 22490330
[TBL] [Abstract][Full Text] [Related]
33. Concurrent TP53 mutations predict a poor prognosis of EGFR-mutant NSCLCs treated with TKIs: An updated systematic review and meta-analysis.
Lan B; Zhao N; Du K; Leng B
Oncol Lett; 2022 Nov; 24(5):384. PubMed ID: 36238360
[TBL] [Abstract][Full Text] [Related]
34. Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-analysis.
Short NJ; Zhou S; Fu C; Berry DA; Walter RB; Freeman SD; Hourigan CS; Huang X; Nogueras Gonzalez G; Hwang H; Qi X; Kantarjian H; Ravandi F
JAMA Oncol; 2020 Dec; 6(12):1890-1899. PubMed ID: 33030517
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis.
Yi-Ning Y; Xiao-rui W; Chu-xian Z; Chun W; You-wen Q
Ann Hematol; 2015 Jun; 94(6):929-38. PubMed ID: 25572170
[TBL] [Abstract][Full Text] [Related]
36. The prognostic impact of cigarette smoking on survival in acute myeloid leukemia with TP53 mutations and/or 17p deletions.
Bi X; French Z; Palmisiano N; Wen KY; Wilde L
Ann Hematol; 2022 Jun; 101(6):1251-1259. PubMed ID: 35288759
[TBL] [Abstract][Full Text] [Related]
37. TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.
Hou HA; Chou WC; Kuo YY; Liu CY; Lin LI; Tseng MH; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Li CC; Huang SY; Ko BS; Hsu SC; Chen CY; Lin CT; Wu SJ; Tsay W; Chen YC; Tien HF
Blood Cancer J; 2015 Jul; 5(7):e331. PubMed ID: 26230955
[TBL] [Abstract][Full Text] [Related]
38. The prognostic impact of TP53 comutation in EGFR mutant lung cancer patients: a systematic review and meta-analysis.
Zhang R; Tian P; Chen B; Wang T; Li W
Postgrad Med; 2019 Apr; 131(3):199-206. PubMed ID: 30798634
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of AML-MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC-defining criteria, TP53 allelic state, or TP53 variant allele frequency.
Zhao D; Eladl E; Zarif M; Capo-Chichi JM; Schuh A; Atenafu E; Minden M; Chang H
Cancer Med; 2023 Mar; 12(6):6511-6522. PubMed ID: 36394085
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of ASXL1 mutations in acute myeloid leukemia: A systematic review and meta-analysis.
Sheikhi M; Rostami M; Ferns G; Ayatollahi H; Siyadat P; Ayatollahi Y; Khoshnegah Z
Caspian J Intern Med; 2024; 15(2):202-214. PubMed ID: 38807730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
